CAS: 639858-32-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
N-Cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]benzamide REF: AN-AG01ENIMCAS: 639858-32-5 | ≥98%(HPLC) | 224,00 €~1.048,00 € | Vie 03 May 24 | |
BMS-605541 REF: TM-T26852CAS: 639858-32-5 | 98.07% | 39,00 €~590,00 € | Lun 06 May 24 | |
BMS 605541 REF: 3D-PAB85832CAS: 639858-32-5 | Min. 95% | A consultar | Vie 14 Jun 24 |
N-Cyclopropyl-2,4-difluoro-5-[[[2-(2-pyridinylamino)-5-thiazolyl]methyl]amino]benzamide
CAS:639858-32-5
Fórmula:
C19H17F2N5OS
Pureza:
≥98%(HPLC)
Peso molecular:
401.4330
Ref: AN-AG01ENIM
5mg | 224,00 € | |
10mg | 301,00 € | |
50mg | 1.048,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
BMS-605541
CAS:639858-32-5
BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase …
Fórmula:
C19H17F2N5OS
Pureza:
98.07%
Forma y color:
Solid
Peso molecular:
401.43
Ref: TM-T26852
1mg | 39,00 € | |
5mg | 82,00 € | |
10mg | 118,00 € | |
25mg | 246,00 € | |
50mg | 397,00 € | |
100mg | 590,00 € | |
1ml*10 (DMSO) | 91,00 € |
Entrega estimada en Estados Unidos, el Lunes 6 de Mayo de 2024
BMS 605541
CAS:639858-32-5
Pemetrexed is a chemotherapeutic drug that has been approved for the treatment of cancer. It …
Fórmula:
C19H17F2N5OS
Pureza:
Min. 95%
Peso molecular:
401.4 g/mol
Ref: 3D-PAB85832
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024